Crossmark

Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13017-018-0183-4

Published Online: 2018-06-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Kirkpatrick, Andrew W. https://orcid.org/0000-0002-1692-5919
Coccolini, Federico

Ansaloni, Luca

Roberts, Derek J.

Tolonen, Matti

McKee, Jessica L.

Leppaniemi, Ari

Faris, Peter

Doig, Christopher J.

Catena, Fausto

Fabian, Timothy

Jenne, Craig N.

Chiara, Osvaldo

Kubes, Paul

Manns, Braden

Kluger, Yoram

Fraga, Gustavo P.

Pereira, Bruno M.

Diaz, Jose J.

Sugrue, Michael

Moore, Ernest E.

Ren, Jianan

Ball, Chad G.

Coimbra, Raul

Balogh, Zsolt J.

Abu-Zidan, Fikri M.

Dixon, Elijah

Biffl, Walter

MacLean, Anthony

Ball, Ian

Drover, John

McBeth, Paul B.

Posadas-Calleja, Juan G.

Parry, Neil G.

Di Saverio, Salomone

Ordonez, Carlos A.

Xiao, Jimmy

Sartelli, Massimo
Funding

Funding for this research was provided by:

Acelity
License Information

Text and Data Mining valid from 2018-06-22
More Information

Article History

Received: 9 April 2018

Accepted: 10 May 2018

First Online: 22 June 2018

Ethics approval and consent to participate

: The COOL trial has been ethically approved at the lead and pilot center by the Conjoint Health Research Ethics Board (CHREB) of the University of Calgary (REB16-1588). The study has also been registered with the National Institutes of Health (, identifier: NCT03163095).

: Andrew W. Kirkpatrick serves in the Canadian Forces Medical Services and has consulted for the Innovative Trauma Care and Acelity Corporations. Jessica L. McKee declares that she has consulted for Innovative Trauma Care, Aceso, and the Acelity Corporations. Osvaldo Chiara reported having consulted for the Acelity Corporation. Jose J. Diaz reported having consulted for the Acelity Corporation. Michael Sugrue reported having consulted for the Smith and Nephew Corporation. Ernest E. Moore reported Research support and intellectual property related to the Haemonetics, TEM Systems, Pryor Corporations, and being a Cofounder of Thrombo Therapeutics Inc. The remaining authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below